There are no products in this category.
View our top selling research chemicals below:
Methoxetamine or 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone is also known as MKET or MXE.
Methoxetamine is chemically similar to ketamine and PCP and is understood to produce similar results. That has made it popular in recreational circles meaning scientific research into the effects and long term ramifications of its use is paramount.
Our limited knowledge of Methoxetamine is that it is a dissociative and sedative. It is a chemical of the arylcyclohexylamine class and has yet to be scientifically profiled. As a result of recreational misuse, the Home Office have categorised it under temporary class drug control under the Misuse of Drugs Act.
As ketamine is used widely in animal welfare, any close analogue of the substance is of considerable interest to science. Also, as ketamine has also found its way onto the recreational drug scene, the more we know about it the better we can understand its effects.
Also, inference that Methoxetamine is “bladder friendly” as noted on Wikipedia could make it worthy of further study. Ketamine is believed to cause long-term bladder damage. It would be useful for researchers to examine this claim to verify the legitimacy of it.
In April 2012, Methoxetamine was placed under a temporary class drug control order, meaning it is technically illegal under the Misuse of Drugs Act. Previously, researchers were able to buy Methoxetamine online from legitimate sources to conduct trials, but this is no longer the case.
There are illegal sources of cheap Methoxetamine UK and abroad, but these should not be considered suitable for research as there is no guarantee of purity, or indeed content. Researchers should only buy Methoxetamine from legitimate sources or wait until the temporary control order lapses, which is generally 12 months after issue.
While Methoxetamine remains in popular use, the media and the government will seek to control the drug. They will also seek to better understand its effects, opening it up once more to the research community.